[What's new in pediatric dermatology in 2011?].
Based on the review of the medical publications, this article summarizes the main advances in the field of pediatric dermatology which occurred during the last year. The main results concern psoriasis, atopic dermatitis, acne and hemangiomas. A particular attention was given to genodermatoses.
Service de dermatologie, centre de référence des maladies génétiques à expression cutanée, hôpital Necker-Enfants Malades, Université Paris Descartes-Paris V, 149 rue de sèvres 75015 Paris, France. smail.hadj@inserm.fr
S
S
Hadj-Rabia
D001288:Attention; D002648:Child; D003863:Depression / Q000209:etiology; D003879:Dermatologic Agents / Q000627:therapeutic use; D003880:Dermatology / Q000639:trends*; D000068800:Etanercept; D005128:Eye Diseases / Q000209:etiology; D006801:Humans; D007074:Immunoglobulin G / Q000627:therapeutic use; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D015474:Isotretinoin / Q000627:therapeutic use; D009154:Mutation; D011433:Propranolol / Q000627:therapeutic use; D051057:Proto-Oncogene Proteins c-akt / Q000235:genetics; D018124:Receptors, Tumor Necrosis Factor / Q000627:therapeutic use; D012720:Severity of Illness Index; D012871:Skin Diseases / Q000150:complications / Q000209:etiology* / Q000523:psychology / Q000628:therapy*; D012878:Skin Neoplasms / Q000150:complications; D014665:Vasodilator Agents / Q000627:therapeutic use; D014807:Vitamin D / Q000097:blood
D003879:Dermatologic Agents; D007074:Immunoglobulin G; D007166:Immunosuppressive Agents; D018124:Receptors, Tumor Necrosis Factor; D014665:Vasodilator Agents; D014807:Vitamin D; D011433:Propranolol; D051057:Proto-Oncogene Proteins c-akt; D015474:Isotretinoin; D000068800:Etanercept